53 related articles for article (PubMed ID: 38579432)
21. Risperidone versus other atypical antipsychotics for schizophrenia.
Komossa K; Rummel-Kluge C; Schwarz S; Schmid F; Hunger H; Kissling W; Leucht S
Cochrane Database Syst Rev; 2011 Jan; (1):CD006626. PubMed ID: 21249678
[TBL] [Abstract][Full Text] [Related]
22. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
23. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
Barber S; Olotu U; Corsi M; Cipriani A
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
[TBL] [Abstract][Full Text] [Related]
24. Clozapine versus other atypical antipsychotics for schizophrenia.
Asenjo Lobos C; Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Leucht S
Cochrane Database Syst Rev; 2010 Nov; (11):CD006633. PubMed ID: 21069690
[TBL] [Abstract][Full Text] [Related]
25. Quetiapine versus other atypical antipsychotics for schizophrenia.
Komossa K; Rummel-Kluge C; Schmid F; Hunger H; Schwarz S; Srisurapanont M; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Jan; (1):CD006625. PubMed ID: 20091600
[TBL] [Abstract][Full Text] [Related]
26. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
Mukundan A; Faulkner G; Cohn T; Remington G
Cochrane Database Syst Rev; 2010 Dec; (12):CD006629. PubMed ID: 21154372
[TBL] [Abstract][Full Text] [Related]
27. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S
Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814
[TBL] [Abstract][Full Text] [Related]
28. Ziprasidone versus other atypical antipsychotics for schizophrenia.
Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; Bhoopathi PS; Kissling W; Leucht S
Cochrane Database Syst Rev; 2009 Oct; (4):CD006627. PubMed ID: 19821380
[TBL] [Abstract][Full Text] [Related]
29. Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics.
Cohrs S
CNS Drugs; 2008; 22(11):939-62. PubMed ID: 18840034
[TBL] [Abstract][Full Text] [Related]
30. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
31. Aripiprazole versus other atypical antipsychotics for schizophrenia.
Khanna P; Suo T; Komossa K; Ma H; Rummel-Kluge C; El-Sayeh HG; Leucht S; Xia J
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD006569. PubMed ID: 24385408
[TBL] [Abstract][Full Text] [Related]
32. Aripiprazole versus other atypical antipsychotics for schizophrenia.
Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
[TBL] [Abstract][Full Text] [Related]
33. The effects of second generation antipsychotic drugs on sleep variables in healthy subjects and patients with schizophrenia.
Monti JM; Torterolo P; Pandi Perumal SR
Sleep Med Rev; 2017 Jun; 33():51-57. PubMed ID: 27321864
[TBL] [Abstract][Full Text] [Related]
34. Risperidone (depot) for schizophrenia.
Sampson S; Hosalli P; Furtado VA; Davis JM
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222
[TBL] [Abstract][Full Text] [Related]
35. Impact of atypical antipsychotics on quality of life in patients with schizophrenia.
Awad AG; Voruganti LN
CNS Drugs; 2004; 18(13):877-93. PubMed ID: 15521791
[TBL] [Abstract][Full Text] [Related]
36. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
Temmingh HS; Williams T; Siegfried N; Stein DJ
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011057. PubMed ID: 29355909
[TBL] [Abstract][Full Text] [Related]
37. Weight and body mass index increase in children and adolescents exposed to antipsychotic drugs in non-interventional settings: a meta-analysis and meta-regression.
Pozzi M; Ferrentino RI; Scrinzi G; Scavone C; Capuano A; Radice S; Nobile M; Formisano P; Clementi E; Bravaccio C; Carnovale C; Pisano S
Eur Child Adolesc Psychiatry; 2022 Jan; 31(1):21-37. PubMed ID: 32617775
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews.
Melnik T; Soares BG; Puga ME; Atallah AN
Sao Paulo Med J; 2010 May; 128(3):141-66. PubMed ID: 20963366
[TBL] [Abstract][Full Text] [Related]
39. Aripiprazole versus other atypical antipsychotics for schizophrenia.
Komossa K; Rummel-Kluge C; Schmid F; Hunger H; Schwarz S; El-Sayeh HG; Kissling W; Leucht S
Cochrane Database Syst Rev; 2009 Oct; (4):CD006569. PubMed ID: 19821375
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
